Smoking: A risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients - Absence of evidence or evidence of absence?

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 1, 2008, Pages 226-236

  Orth, Stephan R ^a,b,d   Hallan, Stein I ^c,e  

^a Neurological Clinic Bad Aibling   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d St Olav University Hospital ^*  (Germany)

^e TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DISEASE COURSE; HUMAN; MORBIDITY; MORTALITY; REVIEW; RISK FACTOR; SMOKING;

CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; HUMANS; MORBIDITY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SMOKING;

EID: 38749147769     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03740907     Document Type: Review

References (127)

1. Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, Atkins RC: Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol 14: S131-S138, 2003
2. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12, 2003
3. Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, Hallan HA, Lydersen S, Holmen J: International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 17: 2275-2284, 2006
4. Kiberd B: The chronic kidney disease epidemic: Stepping back and looking forward. J Am Soc Nephrol 17: 2967-2973, 2006
5. White SL, Cass A, Atkins RC, Chadban SJ: Chronic kidney disease in the general population. Adv Chronic Kidney Dis 12: 5-13, 2005
6. Dirks JH, de Zeeuw D, Agarwal SK, Atkins RC, Correa-Rotter R, D'Amico G, Bennett PH, El Nahas M, Valdes RH, Kaseje D, Katz IJ, Naicker S, Rodriguez-Iturbe B, Schieppati A, Shaheen F, Sitthi-Amorn C, Solez K, Viberti G, Remuzzi G, Weening JJ, International Society of Nephrology Commission for the Global Advancement of Nephrology Study Group 2004: Prevention of chronic kidney and vascular disease: Toward global health equity - The Bellagio 2004 Declaration. Kidney Int Suppl S1-S6, 2005
7. Perico N, Codreanu I, Schieppati A, Remuzzi G: The future of renoprotection. Kidney Int Suppl S95-S101, 2005
8. Amann K, Wanner C, Ritz E: Cross-talk between the kidney and the cardiovascular system. J Am Soc Nephrol 17: 2112-2119, 2006
9. McCullough PA: Cardiovascular disease in chronic kidney disease from a cardiologist's perspective. Curr Opin Nephrol Hypertens 13: 591-600, 2004
10. Orth SR: Effects of smoking on systemic and intrarenal hemodynamics: Influence on renal function. J Am Soc Nephrol 15[Suppl 1]: S58-S63, 2004
11. Orth SR: Cigarette smoking: An important risk factor - Far beyond carcinogenesis. Tob Induced Dis 1: 137-155, 2002
12. Orth SR: Smoking and the kidney. J Am Soc Nephrol 13: 1663-1672, 2002
13. ANZDATA Registry: Annual report. Available at http://www.anzdata.org.au/ anzdata/AnzdataReport/29thReport/Ch02NewPatients.pdf. Accessed November 6, 2007
14. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J: Blood pressure and endstage renal disease in men. N Engl J Med 334: 13-18, 1996
15. Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, de Jong PE: Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 133: 585-591, 2000
16. Halimi JM, Giraudeau B, Vol S, Cacès E, Nivet H, Lebranchu Y, Tichet J: Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int 58: 1285-1292, 2000
17. Briganti EM, Branley P, Chadban SJ, Shaw JE, McNeil JJ, Welborn TA, Atkins RC: Smoking is associated with renal impairment and proteinuria in the normal population: The AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis 40: 704-712, 2002
18. Orth SR, Ritz E: Adverse effect of smoking on renal function in the general population: Are men at higher risk? Am J Kidney Dis 40: 864-866, 2002
19. Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, Appel RG: Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an older population. Kidney Int 57: 2072-2079, 2000
20. Verhave JC, Hillege HL, Burgerhof JG, Gansevoort RT, de Zeeuw D, de Jong PE, PREVEND Study Group: The association between atherosclerotic risk factors and renal function in the general population. Kidney Int 67: 1967-1973, 2005
21. Vupputuri S, Sandler DP: Lifestyle risk factors and chronic kidney disease. Ann Epidemiol 13: 712-720, 2003
22. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J: Risk factors for chronic kidney disease: A prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 14: 2934-2941, 2003
23. Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, Neaton JD: Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of endstage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol 17: 1444-1452, 2006
24. Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A: Risk factors for chronic kidney disease in a community-based population: A 10-year follow-up study. Kidney Int 71: 159-166, 2007
25. Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarød K, Holmen J: Obesity, smoking, and physical inactivity as risk factors for CKD: Are men more vulnerable? Am J Kidney Dis 47: 396-405, 2006
26. Baggio B, Budakovic A, Perissinotto E, Maggi S, Cantaro S, Enzi G, Grigoletto F, ILSA Working Group: Atherosclerotic risk factors and renal function in the elderly: The role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA). Nephrol Dial Transplant 20: 114-123, 2005
27. Joshi VD, Mooppil N, Lim J: Prevalence and risk factors of undetected proteinuria in an elderly South-East Asian population. Nephrology (Carlton) 11: 347-354, 2006
28. Ejerblad E, Fored CM, Lindblad P, Fryzek J, Dickman PW, Elinder CG, McLaughlin JK, Nyrén O: Association between smoking and chronic renal failure in a nationwide population-based case-control study. J Am Soc Nephrol 15: 2178-2185, 2004
29. de Boer IH, Sibley SD, Kestenbaum B, Sampson JN, Young B, Cleary PA, Steffes MW, Weiss NS, Brunzell JD, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group: Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol 18: 235-243, 2007
30. Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH: Progression of nephropathy in type 2 diabetic patients. Kidney Int 66: 1596-1605, 2004
31. Chuahirun T, Wesson DE: Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition. Am J Kidney Dis 39: 376 -382, 2002
32. Keeton GR, Smit RZ, Bryer A: Renal outcome of type 2 diabetes in South Africa: A 12-year follow-up study. S Afr Med J 94: 771-775, 2004
33. Scott LJ, Warram JH, Hanna LS, Laffel LM, Ryan L, Krolewski AS: A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes 50: 2842-2849, 2001
34. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG: Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective. Kidney Int 69: 2057-2063, 2006
35. Orth SR, Schroeder T, Ritz E, Ferrari P: Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant 20: 2414-2419, 2005
36. Warmoth L, Regalado MM, Simoni J, Harrist RB, Wesson DE: Cigarette smoking enhances increased urine albumin excretion as a risk factor for glomerular filtration rate decline in primary hypertension. Am J Med Sci 330: 111-119, 2005
37. Perry HM Jr, Miller JP, Fornoff JR, Baty JD, Sambhi MP, Rutan G, Moskowitz DW, Carmody SE: Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 25: 587-594, 1995
38. Orth SR, Stockmann A, Conradt C, Ritz E, Ferro M, Kreusser W, Piccoli G, Rambausek M, Roccatello D, Schäfer K, Sieberth HG, Wanner C, Watschinger B, Zucchelli P: Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 54: 926-931, 1998
39. Paterson AD, Magistroni R, He N, Wang K, Johnson A, Fain PR, Dicks E, Parfrey P, St George-Hyslop P, Pei Y: Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 16: 755-762, 2005
40. Font J, Ramos-Casals M, Cervera R, García-Carrasco M, Torras A, Sisó A, Darnell A, Ingelmo M: Cardiovascular risk factors and the long-term outcome of lupus nephritis. QJM 94: 19-26, 2001
41. Ward MM, Studenski S: Clinical prognostic factors in lupus nephritis: The importance of hypertension and smoking. Arch Intern Med 152: 2082-2088, 1992
42. Joosten SA, Sijpkens YW, van Kooten C, Paul LC: Chronic renal allograft rejection: pathophysiologic considerations. Kidney Int 68: 1-13, 2005
43. Lin SJ, Koford JK, Baird BC, Hurdle JF, Krikov S, Habib AN, Goldfarb-Rumyantzev AS: Effect of donors' intravenous drug use, cigarette smoking, and alcohol dependence on kidney transplant outcome. Transplantation 80:482-486, 2005
44. Matas AJ, Payne WD, Sutherland DE, Humar A, Gruessner RW, Kandaswamy R, Dunn DL, Gillingham KJ, Najarian JS: 2,500 living donor kidney transplants: A single-center experience. Ann Surg 234: 149-164, 2001
45. Zitt N, Kollerits B, Neyer U, Mark W, Heininger D, Mayer G, Kronenberg F, Lhotta K: Cigarette smoking and chronic allograft nephropathy. Nephrol Dial Transplant 22: 3034-3039, 2007
46. Fellstrom B, Holdaas H, Jardine AG, Nyberg G, Gronhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambuhl P, Olsson AG, Staffier B, Pedersen TR, Assessment of Lescol in Renal Transplantation Study Investigators: Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial. Transplantation 79: 205-212, 2005
47. Odoni G, Ogata H, Viedt C, Amann K, Ritz E, Orth SR: Cigarette smoke condensate aggravates renal injury in the renal ablation model. Kidney Int 61: 2090-2098, 2002
48. Jaimes EA, Tian RX, Raij L: Nicotine: The link between cigarette smoking and the progression of renal injury? Am J Physiol Heart Circ Physiol 292: H76-H82, 2007
49. Dasgupta P, Chellappan SP: Nicotine-mediated cell proliferation and angiogenesis: New twists to an old story. Cell Cycle 5: 2324-2328, 2006
50. Mur C, Claria J, Rodela S, Lario S, Campistol JM, Titos E, Iñigo P, Cases A, Abián J, Esmatjes E: Cigarette smoke concentrate increases 8-epi-PGF2alpha and TGFbeta1 secretion in rat mesangial cells. Life Sci 75: 611-621, 2004
51. Chuahirun T, Simoni J, Hudson C, Seipel T, Khanna A, Harrist RB, Wesson DE: Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am J Med Sci 327: 57-67, 2004
52. Esmatjes E, Flores L, Lario S, Clària J, Cases A, Iñigo P, Campistol JM: Smoking increases serum levels of transforming growth factor-beta in diabetic patients. Diabetes Care 22: 1915-1916, 1999
53. Cucina A, Corvino V, Sapienza P, Borrelli V, Lucarelli M, Scarpa S, Strom R, Santoro-D' Angelo L, Cavallaro A: Nicotine regulates basic fibroblastic growth factor and transforming growth factor beta1 production in endothelial cells. Biochem Biophys Res Commun 257: 306-312, 1999
54. Galazyn-Sidorczuk M, Brzoska MM, Moniuszko-Jakoniuk J: Estimation of Polish cigarettes contamination with cadmium and lead, and exposure to these metals via smoking. Environ Monit Assess May 17, 2007 [epub ahead of print]
55. Barbier O, Jacquillet G, Tauc M, Cougnon M, Poujeol P: Effect of heavy metals on, and handling by, the kidney. Nephron Physiol 99: 103-110, 2005
56. EL Safty IA, Afifi AM, Shournan AE, EL Sady AK: Effects of smoking and lead exposure on proximal tubular integrity among Egyptian industrial workers. Arch Med Res 35: 59-65, 2004
57. EL Safty IA, Shouman AE, Amin NE: Nephrotoxic effects of mercury exposure and smoking among Egyptian workers in a fluorescent lamp factory. Arch Med Res 34: 50-55, 2003
58. EL Safty IA, Gadallah M, Shouman AE, Nessim DE: Subclinical nephrotoxicity caused by smoking and occupational silica exposure among Egyptian industrial workers. Arch Med Res 34: 415-421, 2003
59. Satarug S, Ujjin P, Vanavanitkun Y, Nishijo M, Baker JR, Moore MR: Effects of cigarette smoking and exposure to cadmium and lead on phenotypic variability of hepatic CYP2A6 and renal function biomarkers in men. Toxicology 204: 161-173, 2004
60. Diamond GL, Thayer WC, Choudhury H: Pharmacokinetics/pharmacodynamics (PK/PD) modeling of risks of kidney toxicity from exposure to cadmium: Estimates of dietary risks in the U.S. population. J Toxicol Environ Health A 66: 2141-2164, 2003
61. Ikeda M, Ezaki T, Moriguchi J, Fukui Y, Okamoto S, Ukai H, Sakurai H: No meaningful increase in urinary tubular dysfunction markers in a population with 3 microg cadmium/g creatinine in urine. Biol Trace Elem Res 113: 35-44, 2006
62. Satarug S, Moore MR: Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ Health Perspect 112: 1099-1103, 2004
63. Omvik P: How smoking affects blood pressure. Blood Press 5: 71-77, 1996
64. Hansen KW, Pedersen MM, Christiansen JS, Mogensen CE: Night blood pressure and cigarette smoking: Disparate association in healthy subjects and diabetic patients. Blood Press 3: 381-388, 1994
65. Davidson MB, Hix JK, Vidt DG, Brotman DJ: Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med 166: 846-852, 2006
66. Giles TD: Circadian rhythm of blood pressure and the relation to cardiovascular events. J Hypertens Suppl 24: S11-S16, 2006
67. Trap-Jensen J: Effects of smoking on the heart and peripheral circulation. Am Heart J 115: 263-267, 1988
68. Matsui Y, Kario K, Ishikawa J, Hoshide S, Eguchi K, Shimada K: Smoking and antihypertensive medication: Interaction between blood pressure reduction and arterial stiffness. Hypertens Res 28: 631-638, 2005
69. Benck U, Clorius JH, Zuna I, Ritz E: Renal hemodynamic changes during smoking: Effects of adrenoreceptor blockade. Eur J Clin Invest 29: 1010-1018, 1999
70. Bangstad HJ, Osterby R, Rudberg S, Hartmann A, Brabrand K, Hanssen KF: Kidney function and glomerulopathy over 8 years in young patients with type I (insulin-dependent) diabetes mellitus and microalbuminuria. Diabetologia 45: 253-261, 2002
71. Baggio B, Budakovic A, Dalla Vestra M, Saller A, Bruseghin M, Fioretto P: Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. J Am Soc Nephrol 13: 2730-2736, 2002
72. Lhotta K, Rumpelt HJ, Konig P, Mayer G, Kronenberg F: Cigarette smoking and vascular pathology in renal biopsies. Kidney Int 61: 648-654, 2002
73. Myllymaki J, Honkanen T, Syrjanen L Helin H, Rantala I, Pasternack A, Mustonen J: Uric acid correlates with the severity of histopathological parameters in IgA nephropathy. Nephrol Dial Transplant 20: 89-95, 2005
74. Goforth RL, Rennke H, Sethi S: Renal vascular sclerosis is associated with inherited thrombophilias. Kidney Int 70: 743-750, 2006
75. Markowitz GS, Lin J, Valeri AM, Avila C, Nasr SH, D'Agati VD: Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking. Hum Pathol 33: 826-835, 2002
76. Kuppachi S, Idris N, Chander PN, Yoo J: Idiopathic nodular glomerulosclerosis in a non-diabetic hypertensive smoker: Case report and review of literature. Nephrol Dial Transplant 21: 3571-3575, 2006
77. Nasr SH, D'Agati VD: Nodular glomerulosclerosis in the nondiabetic smoker. J Am Soc Nephrol 18: 2032-2036, 2007
78. Liang KV, Greene EL, Oei LS, Lewin M, Lager D, Sethi S: Nodular glomerulosclerosis: Renal lesions in chronic smokers mimic chronic thrombotic microangiopathy and hypertensive lesions. Am J Kidney Dis 49: 552-559, 2007
79. United States Renal Data System: USRDS Annual Data Report. Available at http://www.usrds.org/adr_2006.htm. Accessed November 6, 2007
80. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 17: 2034-2047, 2006
81. Muntner P, He J, Hamm L, Loria C, Whelton PK: Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13: 745-753, 2002
82. Jungers P, Massy ZA, Nguyen Khoa T, Fumeron C, Labrunie M, Lacour B, Descamps-Latscha B, Man NK: Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: A prospective study. Nephrol Dial Transplant 12: 2597-2602, 1997
83. Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B: Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors. JAMA 293: 1737-1745, 2005
84. Muntner P, He J, Astor BC, Folsom AR, Coresh J: Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: Results from the Atherosclerosis Risk in Communities study. J Am Soc Nephrol 16: 529-538, 2005
85. de Vinuesa SG, Ortega M, Martinez P, Goicoechea M, Campdera FG, Luñao J: Subclinical peripheral arterial disease in patients with chronic kidney disease: Prevalence and related risk factors. Kidney Int Suppl S44-S47, 2005
86. Stack AG: Coronary artery disease and peripheral vascular disease in chronic kidney disease: An epidemiological perspective. Cardiol Clin 23: 285-298, 2005
87. Selvin E, Erlinger TP: Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110: 738-743, 2004
88. Myllymaki J, Syrjanen J, Helin H, Pasternack A, Kattainen A, Mustonen J: Vascular diseases and their risk factors in IgA nephropathy. Nephrol Dial Transplant 21: 1876-1882, 2006
89. Chan WB, Chan NN, Lai CW, So WY, Lo MK, Lee KF, Chow CC, Metreweli C, Chan JC: Vascular defect beyond the endothelium in type II diabetic patients with overt nephropathy and moderate renal insufficiency. Kidney Int 70: 711-716, 2006
90. Cao JJ, Arnold AM, Manolio TA, Polak JF, Psaty BM, Hirsch CH, Kuller LH, Cushman M: Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: The Cardiovascular Health Study. Circulation 116: 32-38, 2007
91. London GM, Marchais SJ, Guerin AP, Metivier F: Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens 14: 525-531, 2005
92. Koch M, Trapp R, Kulas W, Grabensee B: Critical limb ischaemia as a main cause of death in patients with end-stage renal disease: A single-centre study. Nephrol Dial Transplant 19: 2547-2552, 2004
93. Rajagopalan S, Dellegrottaglie S, Furniss AL, Gillespie BW, Satayathum S, Lameire N, Saito A, Akiba T, Jadoul M, Ginsberg N, Keen M, Port FK, Mukherjee D, Saran R: Peripheral arterial disease in patients with end-stage renal disease: Observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 114: 1914-1922, 2006
94. Stack AG, Bloembergen WE: Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: A cross-sectional study. J Am Soc Nephrol 12: 1516-1523, 2001
95. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58: 353-362, 2000
96. Di Benedetto A, Marcelli D, D'Andrea A, Cice G, D'Isa S, Cappabianca F, Pacchiano G, D'Amato R, Oggero AR, Bonanno D, Pergamo 0, Calabrò R: Risk factors and underlying cardiovascular diseases in incident ESRD patients. J Nephrol 18: 592-598, 2005
97. Foley RN, Herzog CA, Collins AJ: Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 study. Kidney Int 63: 1462-1467, 2003
98. Zoccali C, Tripepi G, Mallamaci F: Predictors of cardiovascular death in ESRD. Semin Nephrol 25: 358-362, 2005
99. Ojo AO: Cardiovascular complications after renal transplantation and their prevention. Transplantation 82: 603-611, 2006
100. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ: Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7: 158-165, 1996
101. Cardinal H, Hebert MJ, Rahme E, Houde I, Baran D, Masse M, Boucher A, Le Lorier J, Elderly Recipients Transplant Group: Modifiable factors predicting patient survival in elderly kidney transplant recipients. Kidney Int 68: 345-351, 2005
102. Cosio FG, Falkenhain ME, Pesavento TE, Yim S, Alamir A, Henry ML, Ferguson RM: Patient survival after renal transplantation: II. The impact of smoking. Clin Transplant 13: 336-341, 1999
103. Ponticelli C, Villa M, Cesana B, Montagnino G, Tarantino A: Risk factors for late kidney allograft failure. Kidney Int 62: 1848-1854, 2002
104. Yango AF, Gohh RY, Monaco AP, Reinert SE, Gautam A, Dworkin LD, Morrissey PE: Excess risk of renal allograft loss and early mortality among elderly recipients is associated with poor exercise capacity. Clin Nephrol 65: 401-407, 2006
105. Chuang P, Gibney EM, Chan L, Ho PM, Parikh CR: Predictors of cardiovascular events and associated mortality within two years of kidney transplantation. Transplant Proc 36: 1387-1391, 2004
106. Ramanathan V, Goral S, Tanriover B, Feurer ID, Kazancioglu R, Shaffer D, Helderman JH: Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation. Transplantation 79: 1453-1458, 2005
107. Lentine KL, Schnitzler MA, Abbott KC, Li L, Burroughs TE, Irish W, Brennan DO De novo congestive heart failure after kidney transplantation: A common condition with poor prognostic implications. Am J Kidney Dis 46: 720-733, 2005
108. Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE, Hamman RE: Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA 265: 614-617, 1991
109. Sawicki PT, Didjurgeit U, Muhlhauser I, Bender R, Heinemann L, Berger M: Smoking is associated with progression of diabetic nephropathy. Diabetes Care 17: 126-131, 1994
110. Gambaro G, Bax G, Fusaro M, Normanno M, Manani SM, Zanella M, Dangelo A, Fedele D, Favaro S: Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus. Diabetes Nutr Metab 14: 337-342, 2001
111. Sung RS, Althoen M, Howell TA, Ojo AO, Merion RM: Excess risk of renal allograft loss associated with cigarette smoking. Transplantation 71: 1752-1757, 2001
112. Ehlers SL, Rodrigue JR, Patton PR, Lloyd-Tumer J, Kaplan B, Howard RJ: Treating tobacco use and dependence in kidney transplant recipients: Development and implementation of a program. Prog Transplant 16: 33-37, 2006
113. Larsen JL, Colling CW, Ratanasuwan T, Burkman TW, Lynch TG, Erickson JM, Lyden ER, Lane JT, Mack-Shipman LR: Pancreas transplantation improves vascular disease in patients with type 1 diabetes. Diabetes Care 27: 1706-1711, 2004
114. Nagele H, Kalmar P, Rodiger W, Stubbe HM: Smoking after heart transplantation: An underestimated hazard? Eur J Cardiothorac Surg 12: 70-74, 1997
115. Kheradmand A, Shahbazian H: The role of pretransplant smoking on allograft survival in kidney recipients. Urol J 2: 36-39, 2005
116. NIH State-of-the-Science Conference statement on tobacco use: Prevention, cessation, and control: NIH Consens State Sci Statements 23: 1-26, 2006
117. Martinez-Ramirez HR, Jalomo-Martinez B, Cortés-Sanabria L, Rojas-Campos E, Barragán G, Alfaro G, Cueto-Manzano AM: Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: A comparative prospective cohort study between primary health care doctors and a nephrologist. Am J Kidney Dis 47: 78-87, 2006
118. Feinson JA, Chidekel AS: What physicians can do about the tobacco problem: Best practice interventions for your practice and office. Del Med J 78: 137-145, 2006
119. Nides M, Leischow S, Sarna L, Evans SE: Maximizing smoking cessation in clinical practice: Pharmacologic and behavioral interventions. Prev Cardiol 10: 23-30, 2007
120. Pederson LL, Blumenthal D: Smoking cessation: What works in primary care settings. Ethn Dis 15: S10-S13, 2005
121. Hobbs SD, Bradbury AW: Smoking cessation strategies in patients with peripheral arterial disease: An evidence-based approach. Eur J Vasc Endovasc Surg 26: 341-347, 2003
122. Frishman WH: Smoking cessation pharmacotherapy: Nicotine and non-nicotine preparations. Prev Cardiol 10: 10-22, 2007
123. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB: A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340: 685-691, 1999
124. Molander L, Hansson A, Lunell E, Alainentalo L, Hoffmann M, Larsson R: Pharmacokinetics of nicotine in kidney failure. Clin Pharmacol Ther 68: 250-260, 2000
125. Worrall SP, Almond MK, Dhillon S: Pharmacokinetics of bupropion and its metabolites in haemodialysis patients who smoke: A single dose study. Nephron Clin Pract 97: c83-c89, 2004
126. Hughes JR, Stead LF, Lancaster T: Antidepressants for smoking cessation. Cochrane Database Syst Rev CDO00031, 2007
127. Gourlay SG, Stead LF, Benowitz; NL: Clonidine for smoking cessation. Cochrane Database Syst Rev CD000058, 2004